136 related articles for article (PubMed ID: 36341566)
21. Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution.
Packer AN; Muraro PA
Exp Hematol; 2007 Mar; 35(3):516-21. PubMed ID: 17309832
[TBL] [Abstract][Full Text] [Related]
22. Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation.
da Rocha LKA; Freschi de Barros S; Bandeira F; Bollini A; Testa LHA; Simione AJ; Souza MOE; Zanetti LP; de Oliveira LCS; Dos Santos ACF; de Souza MP; Colturado VAR; Kalil J; Machado CM; Guilherme L
Front Immunol; 2018; 9():1889. PubMed ID: 30245685
[TBL] [Abstract][Full Text] [Related]
23. T cell repertoire following autologous stem cell transplantation for multiple sclerosis.
Muraro PA; Robins H; Malhotra S; Howell M; Phippard D; Desmarais C; de Paula Alves Sousa A; Griffith LM; Lim N; Nash RA; Turka LA
J Clin Invest; 2014 Mar; 124(3):1168-72. PubMed ID: 24531550
[TBL] [Abstract][Full Text] [Related]
24. [Safety and effectiveness of tumor-ablative chemotherapy combined with low intensity modified conditioning regimen for 30 patients with hematologic malignancies receiving allogeneic hematopoietic stem cell transplantation].
Luo RM; Da WM; Hu B; Si YJ; Zhang XM; Du ZL; Liu QH; Wang Y; Yue Y; Chen W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1047-52. PubMed ID: 25130826
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation.
van Heijst JW; Ceberio I; Lipuma LB; Samilo DW; Wasilewski GD; Gonzales AM; Nieves JL; van den Brink MR; Perales MA; Pamer EG
Nat Med; 2013 Mar; 19(3):372-7. PubMed ID: 23435170
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis.
Yamamoto W; Andou T; Itabashi M; Koyama S; Ishii Y; Numata A; Motohashi K; Hagihara M; Matsumoto K; Fujisawa S
Intern Med; 2016; 55(13):1721-7. PubMed ID: 27374671
[TBL] [Abstract][Full Text] [Related]
27. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
Front Immunol; 2019; 10():1997. PubMed ID: 31507601
[TBL] [Abstract][Full Text] [Related]
28. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
[TBL] [Abstract][Full Text] [Related]
29. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism.
Wu CJ; Chillemi A; Alyea EP; Orsini E; Neuberg D; Soiffer RJ; Ritz J
Blood; 2000 Jan; 95(1):352-9. PubMed ID: 10607724
[TBL] [Abstract][Full Text] [Related]
30. T-cell receptor repertoire usage in hematologic malignancies.
Fozza C; Longinotti M
Crit Rev Oncol Hematol; 2013 Jun; 86(3):201-11. PubMed ID: 23219015
[TBL] [Abstract][Full Text] [Related]
31. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
[TBL] [Abstract][Full Text] [Related]
32. Immune reconstitution and early infectious complications following nonmyeloablative hematopoietic stem cell transplantation.
Busca A; Lovisone E; Aliberti S; Locatelli F; Serra A; Scaravaglio P; Omedè P; Rossi G; Cirillo D; Barbui A; Ghisetti V; Dall'Omo AM; Falda M
Hematology; 2003 Oct; 8(5):303-11. PubMed ID: 14530172
[TBL] [Abstract][Full Text] [Related]
33. Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
Georges GE; Maris M; Sandmaier BM; Malone DG; Feinstein L; Niederweiser D; Shizuru JA; McSweeney PA; Chauncey TR; Agura E; Little MT; Sahebi F; Hegenbart U; Pulsipher MA; Bruno B; Forman S; Woolfrey AE; Radich JP; Blume KG; Storb R
Int J Hematol; 2002 Aug; 76 Suppl 1():184-9. PubMed ID: 12430851
[TBL] [Abstract][Full Text] [Related]
34. The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases.
Maris M; Storb R
Immunol Res; 2003; 28(1):13-24. PubMed ID: 12947221
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
[TBL] [Abstract][Full Text] [Related]
36. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Du JW; Gu JY; Liu J; Cen XN; Zhang Y; Ou Y; Chu B; Zhu P
Leuk Lymphoma; 2007 Aug; 48(8):1618-27. PubMed ID: 17701594
[TBL] [Abstract][Full Text] [Related]
37. Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation.
Mo X; Huang X
Front Med; 2013 Sep; 7(3):306-15. PubMed ID: 23888376
[TBL] [Abstract][Full Text] [Related]
38. [Allogeneic hematopoietic stem cell transplantation in elderly].
Castagna L; Blaise D; Furst S
Bull Cancer; 2011 Aug; 98(8):915-25. PubMed ID: 21835732
[TBL] [Abstract][Full Text] [Related]
39. The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies.
Amoriello R; Greiff V; Aldinucci A; Bonechi E; Carnasciali A; Peruzzi B; Repice AM; Mariottini A; Saccardi R; Mazzanti B; Massacesi L; Ballerini C
Front Immunol; 2020; 11():559. PubMed ID: 32328061
[TBL] [Abstract][Full Text] [Related]
40. Modified busulfan and cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation in the treatment of patients with hematologic malignancies.
Zhao XF; Mao XF; Wan DM; Liu W
Transplant Proc; 2014 Jun; 46(5):1531-5. PubMed ID: 24935325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
